Search company, investor...

Total Raised

$500K

Investors Count

1

Deal Terms

1

Funding, Valuation & Revenue

3 Fundings

ReVision Therapeutics has raised $500K over 3 rounds.

ReVision Therapeutics's latest funding round was a Unattributed VC for $0.5M on December 20, 2011.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/20/2011

Unattributed VC

$0.5M

$99M

0

FY undefined

12/1/2011

Series B

$99M

0

FY undefined

0

4/7/2010

Series A

$99M

0

FY undefined

0

Date

12/20/2011

12/1/2011

4/7/2010

Round

Unattributed VC

Series B

Series A

Amount

$0.5M

Investors

Valuation

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

0

0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

ReVision Therapeutics Deal Terms

1 Deal Term

ReVision Therapeutics's deal structure is available for 1 funding round, including their Unattributed VC from December 20, 2011.

Round

Unattributed VC

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Unattributed VC

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

ReVision Therapeutics Investors

1 Investors

ReVision Therapeutics has 1 investors. Avalon Ventures invested in ReVision Therapeutics's Unattributed VC funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/20/2011

12/20/2011

1
Unattributed VC

Venture Capital

California

First funding

12/20/2011

Last Funding

12/20/2011

Investor

Rounds

1
Unattributed VC

Board Seats

Type

Venture Capital

Location

California

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.